Delivery Order SPE2DB24D9134-SPE2DB25FZCP8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The award, issued on September 19, 2025, carries an ultimate completion date of October 10, 2025, and utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials with a ceiling value of $1,670.13. Awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, this firm fixed-price delivery order carries no set-aside designation. The contract represents a specific product fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,670.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract, which became effective on August 1, 2025, with an ultimate completion date of August 22, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $13,917.75 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 20, 2025, for YF-VAX 1 dose vials. The contract carries an ultimate completion date of September 11, 2025, and was awarded without set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials with a ceiling value of $5,567.10. This firm fixed-price delivery order, issued on August 8, 2025, falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and valid through November 2026. The contract carries no set-aside...
- The Defense Logistics Agency awarded a $7.2K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials. The contract is firm fixed-price with an ultimate completion date of October 7, 2025, and was awarded on September 16, 2025 without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract was awarded on September 19, 2025, with an ultimate completion date of October 10, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,670.13 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order, which carries an ultimate completion date of August 25, 2025, was awarded without a set-aside designation. The delivery order represents a continuation of DMS Pharmaceutical Group's role as a critical...
- The Defense Logistics Agency awarded a $1,670.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for one dose vials of YF-VAX vaccine. The contract, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499.99...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, was awarded without a set-aside designation. The product will be performed and delivered from the awardee's Park Ridge location to...
- SPE2DB24D9134Indefinite Delivery Contract
- SPE2DB24D9134-SPE2DB25FZCP8Delivery Order
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $1,113.42 for YF-VAX 1 dose vials. The award, issued on September 11, 2025, with an ultimate completion date of October 2, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare sites. The YF-VAX vaccine delivery reflects the company's established portfolio of pharmaceutical products and injections supplied to military health facilities. The firm's consistent success in securing DLA contracts without set-aside designations demonstrates its competitive positioning within federal procurement markets, leveraging its woman-owned small business status alongside its extensive pharmaceutical distribution capabilities registered with SAM.gov since 2001.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/11/25 |